|The Akkermansia Company||CEO||Belgium|
Gut microbiota: Recent high-level scientific studies on the clinical validation and benefits of novel food supplements
Michael has 30 years experience from senior roles in Life Science and FMCG, including more than 20 years as CEO in listed and private companies. During that period, he has also served as chairman and held board positions in a number of life science companies.
Before joining The Akkermansia Company, Michael held notable positions as CEO of probiotics company Probi and biotech company BioInvent, both listed on Nasdaq Stockholm. He is a native of Sweden but has worked internationally throughout his career, including ten years in Australia.